Chandan Guha Selected Research

Chandan Guha Research Topics

Disease

58	Neoplasms (Cancer) 01/2021 - 09/2003
15	Liver Diseases (Liver Disease) 11/2019 - 08/2002
10	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 03/2008
9	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 08/2007
8	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2011
7	Radiation Injuries (Radiation Sickness) 11/2016 - 07/2013
6	Acute Radiation Syndrome 01/2022 - 01/2011
5	Liver Neoplasms (Liver Cancer) 11/2020 - 07/2014
5	Squamous Cell Carcinoma of Head and Neck 01/2019 - 07/2007
4	Fibrosis (Cirrhosis) 01/2022 - 07/2014
4	Infections 08/2021 - 01/2003
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2021 - 01/2015
4	Pancreatic Neoplasms (Pancreatic Cancer) 05/2020 - 03/2016
4	Carcinoma (Carcinomatosis) 04/2014 - 12/2002
3	Lung Neoplasms (Lung Cancer) 07/2020 - 01/2006
3	Adenocarcinoma 10/2019 - 08/2007
3	End Stage Liver Disease 01/2019 - 01/2017
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2019 - 07/2007
3	Lewis Lung Carcinoma 03/2017 - 08/2002
3	Hyperbilirubinemia 01/2017 - 01/2012
3	Crigler-Najjar Syndrome 01/2017 - 09/2009
3	Liver Failure 02/2014 - 03/2007
3	Hyperthermia 01/2013 - 08/2007
2	Leukemia 01/2022 - 07/2013
2	Oropharyngeal Neoplasms 01/2022 - 01/2019
2	Thrombocytopenia (Thrombopenia) 01/2022 - 10/2020
2	Carcinogenesis 01/2021 - 09/2003
2	Necrosis 01/2021 - 01/2013
2	COVID-19 11/2020 - 07/2020
2	Breast Neoplasms (Breast Cancer) 01/2020 - 09/2003
2	Melanoma (Melanoma, Malignant) 01/2020 - 11/2019
2	Acute Liver Failure (Fulminant Hepatic Failure) 01/2017 - 07/2014
2	Disease Progression 11/2016 - 10/2014
2	Ascites 07/2014 - 02/2014
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2014 - 12/2002
2	Sarcoma (Soft Tissue Sarcoma) 04/2011 - 02/2008
2	Primary Hyperoxaluria (Oxaluria, Primary) 05/2008 - 03/2005
1	Pneumonia (Pneumonitis) 08/2021
1	Nasopharyngeal Carcinoma 01/2021
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2021
1	Esophageal Neoplasms (Esophageal Cancer) 01/2021
1	Lymphopenia (Lymphocytopenia) 01/2020
1	Margins of Excision 11/2019
1	Rectal Neoplasms (Rectal Cancer) 11/2019
1	Laryngeal Neoplasms (Laryngeal Cancer) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2011
7	Neoplasm Antigens (Tumor Antigens)IBA 08/2014 - 01/2006
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2013
5	Biological ProductsIBA 04/2015 - 12/2002
4	BilirubinIBA 01/2022 - 02/2014
3	Cancer VaccinesIBA 10/2019 - 08/2008
3	AntigensIBA 10/2019 - 02/2008
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2019 - 11/2008
3	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 04/2011
3	flt3 ligand protein (flt3 ligand)IBA 08/2014 - 01/2006
3	VaccinesIBA 01/2013 - 02/2005
2	AlbuminsIBA 01/2022 - 02/2014
2	Pharmaceutical PreparationsIBA 01/2022 - 05/2013
2	Protons (Proton)IBA 01/2021 - 01/2019
2	AndrogensIBA 01/2021 - 11/2014
2	Peptides (Polypeptides)IBA 01/2019 - 08/2007
2	Glucose (Dextrose)FDA LinkGeneric 09/2017 - 02/2014
2	Fluorouracil (Carac)FDA LinkGeneric 01/2017 - 03/2016
2	Gemcitabine FDA Link 11/2016 - 03/2016
2	Glycogen Synthase Kinase 3 betaIBA 12/2015 - 09/2003
2	Pemetrexed (MTA)FDA Link 02/2011 - 07/2007
2	5'-methylthioadenosine phosphorylase (methylthioadenosine nucleosidase)IBA 02/2011 - 07/2007
2	PolyaminesIBA 02/2011 - 07/2007
2	OxalatesIBA 05/2008 - 03/2005
2	4'- deaza- 1'- aza- 2'- deoxy- 1'- (9- methylene)- immucillin AIBA 01/2008 - 07/2007
1	Transforming Growth Factor-beta Type II ReceptorIBA 01/2022
1	Cobalt-60IBA 01/2022
1	durvalumabIBA 03/2021
1	CarbonIBA 01/2021
1	CalreticulinIBA 01/2020
1	Granzymes (Granzyme)IBA 11/2019
1	Interleukin-2 (IL2)IBA 11/2019
1	Trinitrotoluene (TNT)IBA 11/2019
1	A-1210477IBA 01/2019
1	bcl-X ProteinIBA 01/2019
1	navitoclaxIBA 01/2019
1	CholesterolIBA 01/2019

Therapy/Procedure

52	Radiotherapy 01/2022 - 12/2002
45	Therapeutics 01/2022 - 01/2003
13	Transplantation 01/2019 - 08/2002
9	Drug Therapy (Chemotherapy) 01/2022 - 09/2003
9	Immunotherapy 01/2021 - 08/2008
6	Liver Transplantation 01/2019 - 11/2006
5	Chemoradiotherapy 01/2022 - 01/2015
2	Proton Therapy 01/2021 - 01/2019
2	Immunomodulation 01/2020 - 08/2014
2	Radiofrequency Ablation 01/2018 - 01/2013
2	Brachytherapy 11/2012 - 12/2002
1	Molecular Targeted Therapy 01/2021
1	Heavy Ion Radiotherapy 05/2020
1	Radiation Dose Fractionation 01/2020
1	Wearable Electronic Devices 11/2019
1	Injections 11/2019
1	Neoadjuvant Therapy 11/2019